We received great news. Our abstract got accepted to the AHA (American Heart Association). The international convention and presentation of our findings will take place November 2012 in Los Angeles.
We are so excited, especially because we developed a unique technique evaluating mice atherosclerosis lesion in-vivo using micro-ultrasound. We were also testing the benefit of Vitamin E treatment as an antioxidant to prevent plaque growth to diabetic mice.
To get this kind of recognition by the AHA is huge, since it hosts the top researchers from all over the world. It is a great chance to show our findings and get an objective critique and input from the best professionals in the field as well as to look at other colleague accomplishments, new discoveries etc.
To be a part of this convention and this kind of a scientific atmosphere is such a privilege for me personally and I look forward to present our research and publicize the lab of Prof. Levy.
Hilla Lee Viener,
Prof. Andrew Levy's Lab
The Rappaport Faculty of Medicine - Technion